China and Russia plan to build nuclear power station on moon – DW – 05/16/2025
Planned for 2035, the nuclear reactor would power research and exploration of the moon's south pole as part of the the International Lunar Research Station project.
What you need to know:
China and Russia plan to build a nuclear reactor on the moon by 2035 to power a permanent lunar base.
The International Lunar Research Station (ILRS) will rely on the power plant for its scientific research.
The IRLS involves over a dozen international partners and is seen as a rival program to NASA's Artemis Program.
China and Russia plan to build an automated nuclear power station on the moon by 2035.
A memorandum of cooperation for the project was signed between Russia's space agency Roscosmos and the China National Space Administration (CNSA) this week.
The power station will be part of the proposed ILRS lunar base and will provide energy to enable long-term lunar exploration and scientific research.
ILRS is seen as a rival to the US-led Artemis program, which plans to build an orbital lunar space station called "Gateway" from 2027.
Artemis involves NASA and the space agencies of 55 other countries, including European Space Agency member states.
What is the International Lunar Research Station?
The ILRS project aims to establish a scientific research base on the moon located within 100 kilometers (62 miles) of the lunar south pole.
It will feature long-term autonomous operations and short-term human missions.
"The station will conduct fundamental space research and test technology for long-term uncrewed operations of the ILRS, with the prospect of a human being's presence on the Moon," Roscosmos said in a statement.
Chang'e-6: Is geopolitics harming China-EU lunar mission?
To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video
First announced in 2017, ILRS includes involvement from Pakistan, Venezuela, Belarus, Azerbaijan, South Africa, Egypt, Nicaragua, Thailand, Serbia, Senegal and Kazakhstan.
China will also invite 50 countries, 500 international scientific research institutions and 5,000 overseas researchers to join the ILRS as part of its "555 Project," said Wu Weiren, chief designer of China's lunar exploration program in a statement last year.
While the ILRS aims to be a center of scientific research, the Moon's natural resources are also an enticing prospect for spacefaring nations.
The moon holds valuable metal oxides, regolith (lunar soil), rare Earth metals, and potentially significant amounts of helium-3, a potential fuel for nuclear fusion power.
The question of who can actually own bits of the moon is hotly debated among legal experts.
Will China lead future space exploration?
ILRS is part of China's mission to be come a leader in space exploration and scientific research.
The first pieces are to be laid by China's Chang'e-8 mission in 2028. This will double as China's first attempt landing an astronaut on the lunar surface.
China has been landing unmanned rovers on the moon since 2013 and its scientists have led missions that have mapped the lunar surface, including the 'dark side of the moon', which is the lunar hemisphere that always faces away from Earth.
In June 2024, China became the first nation to successfully collect rocks from this hemisphere. The mission was hailed by China, with state news agency Xinhua describing it as "an unprecedented feat in human lunar exploration history."
Edited by: Matthew Ward Agius
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
DW
2 days ago
- DW
The moon: Why we want to go back – DW – 06/02/2025
Almost six decades since humans walked on the moon, space agencies and commercial companies want to use it as a gateway to Mars. But that's not all. What you need to know: The prospect of humans returning to the moon looks more likely than ever, with NASA and ESA collaborating on the Artemis program There have been a number of recent, successful moon missions by China and India Space agencies and commercial companies want to use the moon for scientific research and as a base to get to Mars A growing interest in moon missions The Artemis program is a North American, NASA-led human spaceflight program, involving 55 international collaborators, including the European Space Agency (ESA). NASA aims to establish a permanent base at the moon's South Pole and call it Artemis Base Camp. It also aims to launch a new space station, called Gateway, into the moon's orbit. Meanwhile, a joint China-Russia project, involving 13 international partners, aims to build a moon base called The International Lunar Research Station by 2035. Both the Artemis Base Camp and the International Lunar Research Station are proposed as scientific in nature. They will, if successful, host astronauts for short stays and house permanent robotic equipment, which could be operated from Earth. But the moon has also always been of strategic value, too. During the Cold War, the US and Soviet-era Russia fought out their ideological differences on the moon as well as on Earth. And so it is today, except there are more players. The US, for one, has stated publicly that it considers itself to be in a new space race, which America wants to win. Here are more reasons why. The moon is rich in resources Part of the moon's appeal lies in its abundant resources. These include: Iron Silicon Hydrogen Titanium Rare earth elements While the costs of extraction and transportation are high, some of these resources could be brought back to Earth, where resources are dwindling in supply. Mining operations on the moon could pave the way for extracting an immense mineral wealth held in asteroids, and the moon will be the first place this will be tested. Mining asteroids To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Most material extracted from the moon will be used to replace materials that would otherwise be needed to be brought from Earth, essentially making lunar bases self-sufficient. Regolith (lunar soil), for example, could be used as radiation protection and construction material for lunar bases. Water, which was first discovered on the moon in 2008 by the Indian mission Chandrayaan-1, will be important for drinking, growing food, and cooling equipment. Missions since Chandrayaan-1 have shown there are high concentrations of ice at the lunar poles, which is partly why the first lunar colonies are likely to be built at the poles — and probably at the moon's South Pole, even though it is difficult to land there. These bases could also be used as "transit lounges" for astronauts on their way to Mars. For energy, solar radiation is already used to power some spacecraft and satellites, but regolith and water ice could also be used to make rocket propellant. The moon also contains significant amounts of helium-3, a potential fuel for nuclear fusion power. So, that's another reason future Mars missions are landing for a stopover on the moon and refuel. Scientific research on the moon Scientific research is at the core of ESA's Moon Exploration Programme, as it is for all space agencies, said Sara Pastor, ESA's Lunar and Gateway Program Manager, in an email to DW. Humans have had a continued presence in space for the past 20 years aboard the International Space Station. But the ISS is only 250 miles (~400km) away in low-Earth orbit, which is as little as four hours after launching from Earth. The moon is 250,000 miles away — about three days' spaceflight — and a far riskier journey for astronauts. The first research on the moon aims to make that journey safer and easier. Then there is environmental science: "[Scientists] will investigate the nature of lunar environments, how their unique conditions affect human health and performance, and robotic exploration systems, and how human activity affects these environments," Pastor said. Researchers will want to determine how water, metals, and other lunar resources can be used to sustain lunar bases for the long term, and how best to extract them. "ESA is developing instruments for radiation environment measurements, drilling and in-situ sample analysis, geophysics and lunar space weather," Pastor said. Moon tech benefits us all on Earth It's often claimed that we owe mobile phones to the Apollo missions of the 1960s and 70s. While our mobile phones are not direct descendants from space tech, the Apollo missions did help miniaturize electronic and telecommunication devices. Dozens of modern technologies originally developed in the R&D labs of space agencies bring benefits to people on earth — including home insulation, memory foam (used in mattresses), freeze-dried foods, robotic sensors and limbs, and telemedicine. Scientists are developing medical equipment and health tracking methods to protect astronauts' health when they spend long periods in the extreme conditions of space, especially the human immune system. For example: portable, lightweight diagnostic equipment needed for spaceflight crews without medical training to monitor their health. These technologies could be used on Earth, too. From a lunar hub to a second (or third) home for humans on Mars? The long-term goal of building surface and orbital moon bases is to serve as a staging post for more distant space travel. "A colony on the moon will be extremely useful and a key training ground for Mars surface human exploration," said Pastor. NASA plans to send astronauts to Mars in the 2030s. Edited by: Zulfikar Abbany
Int'l Business Times
2 days ago
- Int'l Business Times
Saudi Arabia Advances Cancer Care with Potential Approval of Multikine Immunotherapy
In a pivotal development in cancer care, Saudi Arabia may become the first country in the world to approve CEL-SCI Corporation 's investigational immunotherapy, Multikine, for commercial use in treating head and neck cancer. The US-based biotech company has submitted an application to the Saudi Food and Drug Authority (SFDA) for Breakthrough Medicine Designation, a fast-track regulatory pathway that could make Multikine available to patients as early as this summer. This move comes after favorable engagement between CEL-SCI and SFDA reviewers announced in April of this year, positioning Saudi Arabia at the forefront of global innovation in oncology. If approved, Multikine would represent a new era in immuno-oncology by becoming the first neoadjuvant (pre-surgical) immunotherapy available for advanced primary head and neck cancer. The Unmet Need in Head and Neck Cancer Head and neck cancers (HNCs) account for 5% of all cancer cases in Saudi Arabia, which is around 650–700 new cases every year. Mostly affecting men attributed to tobacco use, including cigarettes, shisha, and smokeless tobacco like shamma . In the southern provinces like Jazan, shamma use is linked to high oral cancer rates, including among women. Head and neck cancers are often diagnosed at advanced stages, with 80% or more of patients having lymph node involvement at diagnosis. The most common subtypes in the Kingdom are oral cavity and nasopharyngeal carcinomas. Despite advances in surgery and radiation, 5-year survival rates have plateaued at 50%, so there is a big need for more effective first-line treatment options. The Science Behind Multikine Multikine (Leukocyte Interleukin, Injection) is a unique immunotherapeutic biologic composed of a carefully calibrated mix of natural cytokines derived from activated human white blood cells. Unlike checkpoint inhibitors used in later-stage cancers, Multikine is designed to be administered before surgery, while the patient's immune system is still intact and the tumor is present as a target. In CEL-SCI's global Phase III trial , the largest ever conducted in head and neck cancer, Multikine demonstrated a statistically significant improvement in five-year survival rates for a defined patient subgroup: those treated with surgery followed by radiation but not chemotherapy. Among these patients, five-year survival improved from 48.6% to 62.7%, effectively cutting the risk of death nearly in half. Multikine also showed strong safety results, with no late toxicities reported and notable improvements in patient-reported quality of life. Some patients experienced complete tumor regression before surgery, supporting the idea that Multikine may sensitize tumors to subsequent standard treatments. Alignment with Saudi Vision 2030 The approval of Multikine fits perfectly into Saudi Vision 2030 , the national framework for economic diversification and innovation that includes transforming the healthcare and biotech sectors. Central to this transformation is the localization of pharmaceutical manufacturing, attracting clinical research, and becoming a regional hub for medical innovation. The SFDA's Breakthrough Medicine Designation, modeled after similar programs in the U.S. and EU, is a direct byproduct of this strategy. It aims to expedite the approval of therapies that show significant clinical promise in addressing unmet medical needs. By targeting a cancer type with limited first-line advancements, Multikine qualifies as a prime candidate for such accelerated evaluation. Saudi Arabia has also shown leadership in adopting advanced oncology treatments. The country recently became the first in the region to manufacture CAR-T cell therapies domestically, reducing costs and access times for blood cancer patients. The addition of Multikine would continue this trend of delivering next-generation therapeutics within the Kingdom. Oncology Infrastructure Ready for Innovation Saudi Arabia's oncology infrastructure has matured significantly over the last decade. Institutions like King Faisal Specialist Hospital & Research Centre (KFSHRC), King Fahad Medical City (KFMC), and Princess Noorah Oncology Center are now equipped with the latest technologies, including proton therapy and precision diagnostics. These institutions routinely adopt new cancer treatments and maintain specialized head and neck cancer teams composed of ENT surgeons, radiation oncologists, medical oncologists, and rehabilitation professionals. The availability of multidisciplinary tumor boards and growing use of tele-oncology services further support the clinical integration of innovative therapies like Multikine. The Ministry of Health's e-Platform for oncology consultations ensures that even patients in remote regions can access national expertise, which is an essential element as the country decentralizes specialist care under the Vision 2030 framework. Regional and Global Impact If Saudi Arabia approves Multikine in 2025, it will not only be a therapeutic breakthrough for patients but also a model for fast-tracking drug development in the MENA region. CEL-SCI has already announced plans to partner with a local manufacturer in the Kingdom to supply Multikine across the Middle East and North Africa. The implications go beyond geography. An early Saudi approval will strengthen CEL-SCI's case for conditional approvals in other jurisdictions, including Canada and the EU, where the company has filed parallel regulatory submissions. What's Ahead Multikine's journey of over a decade of clinical development is the potential of immunotherapy to improve survival in areas where there are few options. Saudi Arabia's regulatory and clinical leadership may now be the launchpad for this innovation. For patients newly diagnosed with head and neck cancer in the Kingdom, this means more than hope. It soon means potential access.
Int'l Business Times
6 days ago
- Int'l Business Times
The Hunt For Mysterious 'Planet Nine' Offers Up A Surprise
It's an evocative idea that has long bedevilled scientists: a huge and mysterious planet is lurking in the darkness at the edge of our solar system, evading all our efforts to spot it. Some astronomers say the strange, clustered orbits of icy rocks beyond Neptune indicate that something big is out there, which they have dubbed Planet Nine. Now, a US-based trio hunting this elusive world has instead stumbled on what appears to be a new dwarf planet in the solar system's outer reaches. And the existence of this new kid on the block could challenge the Planet Nine theory, the researchers have calculated. Named 2017 OF201, the new object is roughly 700 kilometres (430 miles) across according to a preprint study, which has not been peer-reviewed, published online last week. That makes it three times smaller than Pluto. But that is still big enough to be considered a dwarf planet, lead study author Sihao Cheng of New Jersey's Institute for Advanced Study told AFP. The object is currently three times farther away from Earth than Neptune. And its extremely elongated orbit swings out more than 1,600 times the distance between the Earth and the Sun, taking it into the ring of icy rocks around the solar system called the Oort cloud. It goes so far out, it could have passed by stars other than our Sun in the past, Cheng said. During its 25,000-year orbit, the object is only close enough to Earth to be observed around 0.5 percent of the time, which is roughly a century. "It's already getting fainter and fainter," Cheng said. The discovery suggests "there are many hundreds of similar things on similar orbits" in the Kuiper Belt beyond Neptune, Cheng said. After taking a risk spending more than half a year sorting through a difficult dataset in search of Planet Nine, Cheng said he was "lucky" to have found anything at all. The researchers are requesting time to point the James Webb, Hubble and ALMA telescopes at their discovery. But Sam Deen, a 23-year-old amateur astronomer from California, has already been able to track the dwarf planet candidate through old datasets. "OF201 is, in my opinion, probably one of the most interesting discoveries in the outer solar system in the last decade," Deen told AFP. The icy rocks discovered in the Kuiper belt tend to have a clustered orbit going in a particular direction. Two decades ago, astronomers proposed this was due to the gravitational pull of a world up to 10 times larger than Earth, naming it Planet Nine and kicking off a debate that has rumbled since. It is also sometimes called Planet X, a name proposed for a hypothetical world beyond Neptune more than a century ago. Back in 1930, astronomers were searching for Planet X when they discovered Pluto, which became our solar system's ninth planet. But Pluto turned out to be too tiny -- it is smaller than the Moon -- and was demoted to dwarf planet status in 2006. There are now four other officially recognised dwarf planets, and Cheng believes 2017 OF201 could join their ranks. When the researchers modelled its orbit, they found it did not follow the clustered trend of similar objects. This could pose a problem for the Planet Nine theory, but Cheng emphasised more data is needed. Samantha Lawler of Canada's University of Regina told AFP that this "great discovery" and others like it mean that "the original argument for Planet Nine is getting weaker and weaker". The Vera Rubin Observatory, which is scheduled to go online in Chile this year, is expected to shed light on this mystery, one way or another. Deen said it was discouraging that no sign of Planet Nine has been found so far, but with Vera Rubin "on the horizon I don't think we'll have to wonder about its existence for much longer". For Cheng, he still hopes that this huge planet is out there somewhere. "We're in an era when big telescopes can see almost to the edge of the universe," he said. But what is in our "backyard" still largely remains unknown, he added.
